Peptide Medix product catalog

Research Catalog · peptide family

Protease-Activated Receptors (PAR) — Research Products

9 catalog items

Catalog # Product Type Species Size Price Add to cart
001-89 [Cys0]-PAR-4 (359-385) (Human) Peptides Human 100 µg $286.00 $337.00
001-83 PAR-1 (397-425) (Human) Peptides Human 100 µg $320.00 $377.00
001-88 PAR-3 (352-374) (Human) Peptides Human 100 µg $320.00 $377.00
H-001-88 PAR-3 (352-374) (Human) – Antibody Antiserum Antibodies Human 50 µl $612.00 $720.00
B-G-001-88 PAR-3 (352-374) (Human) – Biotin Labeled Purified IgG Biotin-labeled Labeled Antibodies Human 100 µl $680.00 $800.00
FG-G-001-88A PAR-3 (352-374) (Human) – FAM Labeled Purified IgG Fluorescent-labeled Labeled Antibodies Human 100 µl $680.00 $800.00
T-G-001-88 PAR-3 (352-374) (Human) – I-125 Labeled Purified IgG I-125 labeled Labeled Antibodies Human 10 µCi $1159.00 $1364.00
G-001-88 PAR-3 (352-374) (Human) – Purified IgG Antibody Purified IgG Antibodies Human 200 µg $612.00 $720.00
RP11529 PAR-4 Agonist Peptide, amide Peptides Other species 5 mg $209.00 $246.00

All items are supplied for in vitro laboratory research use only — not for human or veterinary use, diagnosis or therapy. Prices are per unit as listed; each catalog number ships with its Certificate of Analysis.

Protease-Activated Receptors (PAR) — frequently asked

What are protease-activated receptors?
They are G protein-coupled receptors, PAR-1 to PAR-4, activated when a protease cleaves their extracellular amino terminus. The newly exposed sequence acts as a tethered ligand that folds back and engages the receptor's own binding pocket.
What are tethered ligand peptides?
Short synthetic peptides copying the sequence revealed by cleavage can activate the receptor without protease treatment. They are widely used to study PAR signalling selectively, because proteases such as thrombin act on many substrates besides the receptor.
Are the catalogue peptides agonists?
The receptor fragment entries listed here correspond to defined receptor regions and are intended as immunogens, affinity ligands and blocking peptides for antibody work. They are not designed as receptor agonists and should not be assumed to activate signalling.